Previous studies have shown that amyloid-beta (Aβ) plaques are the distinguishing hallmarks of the AD state, and the plaques could activate NF-κB signaling, followed by the release of critical cytokines related to inflammation. Here, NFKB1 is linked to Alzheimer disease.